Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

Dr. Iwao Ojima

TB R&D Update: Podcast Interview with Dr. Iwao Ojima

Dr. Iwao Ojima is a Distinguished Professor and Director of the Institute of Chemical Biology and Drug Discovery at Stony Brook University. In this interview, Dr. Ojima discusses the work his lab has been doing on tri-substituted benzimidazole compou...

Listing to Podcast

View All Podcasts »


UPDATE Exposed: Aeras’ Film Series on Tuberculosis

Release of Chapter 1 of EXPOSED occured the week of May 20. EXPOSED is a four-part series of short films that tell the story of the deadly global epidemic of tuberculosis. The series will portray the struggles of four inspiring individuals - an MDR...

Watch Video

View All Videos »

MSF video

Multidrug-Resistance Tuberculosis: No Promises

A video from Medecins Sans Frontieres entitled "Multidrug-Resistance Tuberculosis: No Promises" on the situation of children affected with MDR-TB. It highlights the dire plight of children being treated for MDR-TB in Tajikistan....

Watch Video

View All Videos »


The Growing Landscape of TB Trials: Interview with Dr. Andrew Vernon

This week we highlight an interview with Dr. Andrew Vernon, the Chief, Clinical Research Branch, Division of Tuberculosis Elimination at the U.S. Centers for Disease Control and Prevention (CDC). He discusses the progress made in TB drug developmen...

Watch Video

View All Videos »

previous next

Messages to our members

2015 WGND Annual Meeting

The 2015 WGND Annual Meeting will take place at the Southern Sun Cape Sun Hotel in Cape Town, South Africa on Saturday, December 5th from 17:30 – 20:30. Register by sending an email to Private Email.

WGND Annual Meeting, Oct. 29th

This meeting will be  held before the 45th Union World Conference on Lung Health on October 29th, from 15:00 to 19:00. Register by sending an email to Private Email.

View All Messages »

From the blog

2015 WGND Annual Meeting and Reception

Cape Town, South Africa, Dec. 5, 17:30 – 20:30 We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ Annual Meeting 2015 at Southern Sun Cape Sun Hotel, Cape Town, South Africa, on Saturday, Dec. 5th from 17:30 to 20:30. This meeting is held before the 46th Union World Conference on [...]

Posted 23 November 2015 | No Comments

Get involved

Site features

Global Discovery Programs

An online tool that invites developers to submit their discovery programs so we can provide a more complete snapshot of current global efforts.

View Pipeline

The Global TB Drugs Pipeline

An online tool that invites developers to submit their TB drug candidates so we can provide a more complete snapshot of current global efforts.

View Pipeline

TB Resources Database

A growing collection of resources to help access Tools, Knowledge, Facilities, and People in the TB drug development R&D community.

View TB Resources

Why We Need New TB Drugs

Today's TB drug regimen takes too long to be effective and requires too many medications. Treatment of drug-sensitive disease requires 6-9 months whereas treatment of drug-resistant TB is even lengthier, taking 18-24 months or longer.

Read More

About us

Our Mission

To accelerate the discovery and development of new drugs for the treatment of tuberculosis by bringing together the stakeholders in TB Drug Development, including the patients themselves.
Read More »

Global Members

The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.
Read More »

Total members: 260

WGND Members:

Basharat Khan

National TB Control Program

Ying Zhang

Johns Hopkins University

Josef Jampilek

UniversityVeterinary and Pharmaceutical Sciences Brno, Faculty of Pharmacy, Department of Chemical Drugs

Heather Ignatius

TB Alliance

Yap Boum II


Richard Chaisson

Johns Hopkins University Center for TB Research

Carol Dukes Hamilton

Family Health International

Malgosia Grzemska

World Health Organization

Yossef Av-Gay

University of British Columbia

Chris Edlin

iThemba Pharmaceuticals

View All Members »